Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NuVasive Reline Cervical System

K-Number: K221388 · 2022-09-09

Decision Date2022-09-09
Product CodeNKG
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

NuVasive Reline Cervical System is a medical device manufactured by Nu Vasive, Incorporated. It received FDA 510(k) clearance on 2022-09-09 under approval number K221388. The device is classified under product code NKG. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NuVasive Reline Cervical System?

NuVasive Reline Cervical System is a medical device that received FDA 510(k) clearance on 2022-09-09. It is manufactured by Nu Vasive, Incorporated. The 510(k) number is K221388.

When was NuVasive Reline Cervical System approved by the FDA?

NuVasive Reline Cervical System received FDA 510(k) clearance on 2022-09-09, under approval number K221388.

What company makes NuVasive Reline Cervical System?

NuVasive Reline Cervical System is manufactured by Nu Vasive, Incorporated.

What is the FDA product code for NuVasive Reline Cervical System?

The FDA product code for NuVasive Reline Cervical System is NKG.

Related Clinical Trials

Other Devices by Nu Vasive, Incorporated

View all 79 devices →

Related Devices (Code: NKG)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.